The University of Chicago Header Logo
Last Name



This is a "connection" page, showing publications co-authored by Michael P Blair and Sarah Rodriguez.

Connection Strength
  1. Rodriguez SH, Schechet SA, Shapiro MJ, Blair MP. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
    View in: PubMed
    Score: 0.850
  2. Rodriguez SH, Peyton C, Lewis K, Andrews B, Greenwald MJ, Schreiber MD, Msall ME, Blair MP. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.794
  3. Blair M, Gonzalez JMG, Snyder L, Schechet S, Greenwald M, Shapiro M, Rodriguez SH. Bevacizumab or laser for aggressive posterior retinopathy of prematurity. Taiwan J Ophthalmol. 2018 Oct-Dec; 8(4):243-248.
    View in: PubMed
    Score: 0.758
  4. Blair MP, Hilkert Rodriguez S, Chan RVP, Shapiro MJ. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
    View in: PubMed
    Score: 0.379
  5. Khanna S, Rodriguez SH, Blair MA, Wroblewski K, Shapiro MJ, Blair MP. Laser Prophylaxis in Patients with Stickler Syndrome. Ophthalmol Retina. 2022 04; 6(4):263-267.
    View in: PubMed
    Score: 0.235
  6. Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Ells AL, Hubbard GB, Martinez-Castellanos MA, Murray TG, Wu WC. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
    View in: PubMed
    Score: 0.229
  7. Zhang DL, Shapiro MJ, Schechet SA, Rabiah PK, Rodriguez SH, Blair MP. Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
    View in: PubMed
    Score: 0.220
  8. Blair MP, Rodriguez SH, Shapiro MJ. A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023.
    View in: PubMed
    Score: 0.218
  9. Zhang MH, Blair MP, Ham SA, Rodriguez SH. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
    View in: PubMed
    Score: 0.217
  10. Rodriguez SH, Blair MP, Shapiro MJ, Berrocal AM, Murray TG, Martinez-Castellanos MA, Hubbard GB. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2020 Apr 01; 145(4).
    View in: PubMed
    Score: 0.210
  11. Schechet SA, Rodriguez SH, Shapiro MJ, Blair MP. Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity". Taiwan J Ophthalmol. 2019 Apr-Jun; 9(2):136-137.
    View in: PubMed
    Score: 0.196
  12. Anand N, Blair MP, Greenwald MJ, Rodriguez SH. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
    View in: PubMed
    Score: 0.195
  13. Theophanous C, Schechet S, Rodriguez SH, Blair M. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.191
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.